Episode 235: Uveitis and Risk Management Panel with Drs. Alla Goldberg, Christopher Henry, and Ashvini Reddy

episode 235.png

Drs. Alla Goldberg, Christopher Henry, and Ashvini Reddy join for a panel discussion of uveitis and risk management, including discussions of monitoring patients on high-risk medications and poor adherence to follow-up.

Relevant Financial Disclosures:

Dr. Sridhar has no relevant disclosures. Dr. Henry has consulted for Clearside and Castle and sits on the advisory board for Aldeyra, Alimera and Clearside. Dr. Reddy has consulted for Clearside. Dr. Goldberg has no financial disclosures.

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.

Jayanth SridharMedical RetinaComment